From BigGo Finance · BigGo Finance · · 1m 10s
TL;DR: JuveLook Patent Lawsuit Slows Baim Sale
Baim's $1.5 billion sale faces delay as Chinese patent lawsuit complicates deal terms.
Baim's sale of its 89.53% stake to Premier Partners is delayed due to a Chinese patent infringement lawsuit filed by Regen Biotech. Baim's $1.5 billion sale faces delay as Chinese patent lawsuit complicates deal terms. Premier Partners sought to sell Baim's 89.53% controlling stake for 2 trillion won (approximately $1.5 billion).
- Baim Sale Deal
- Patent Lawsuit
- South Korean Patents
- Baim Founder Connection
Read the story version — the same reporting as a swipeable deck of 7 cards.






